CAS: 60129-59-1; (2R,3S,5R)-5-(4-Amino-7H-Pyrrolo[2,3-D]Pyrimidin-7-yl)-2-(Hydroxymethyl)Tetrahydrofuran-3-Ol

该化合物是一种核素的模拟物,可能用于医药化学和药物开发,其立体特征确保生物互动具有高度选择性,使其对有针对性的治疗研究具有价值;亚甲二氧基罗丙酰胺运动的存在,增强了其与酶目标的结合性,而氢氧甲基和氢氧基组则有助于溶性与代谢稳定性,该化合物因其结构与天然核素相似,在抗病毒或抗癌剂的研究中特别相关,其定义明确的立体化学和功能组可以进行精确的修改,促进药物研究的结构-活动关系研究.

结构式图片

相似化合物

69-33-0 166247-63-8 908130-61-0

上下游产品

CAS号4330-21-6 1-Α-氯-3,5-二-O-对... | CAS号86402-13-3 4-Amino-7-(2-de... | CAS号90213-66-4 2,4-二氯-7H吡咯[2,3-D]嘧啶 | CAS号39929-79-8 2,4-二羟基吡咯[2,3-d]嘧啶 | CAS号57564-94-0 4-氯-2-(甲硫基)-7H-... | CAS号1500-85-2 4-氨基-7H-吡咯[2,3-d]嘧啶 | CAS号90335-57-2 n4-benzoyl-5'-o... | CAS号95261-09-9 N4-BENZOYL-7-DE...

合成工艺路线路线简述

    📜4-Amino-7-(2-Desoxy-β-D-Erythro-Pentofuranosyl)-2-Methylthio-7H-Pyrrolo(2,3-D)Pyrimidin置于镍体系中,用 N,N-二甲基乙酰胺 作为反应溶剂,化学反应 2.0H,以67%的收率获得产物(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2-(羟甲基)四氢呋喃-3-醇
    参考文献:2'-Deoxytubercidin-通过相转移糖基化合成2'-脱氧腺苷等位基因
    标题:2'-Deoxytubercidin-通过相转移糖基化合成2'-脱氧腺苷等位基因
    摘要:2'-Deoxytubercidin(1),一个2'-Deoxyadenosine(2)的等排物,是通过生色团3A与甲苯酰保护的卤化6的相转移糖基化反应绕过天然前体制备的.在糖基化过程中仅形成β-异头物.碱水解5A的保护基后,获得2'-脱氧-2-(甲硫基)结核菌素(5B),将其用阮内镍脱硫后得到标题化合物1.糖基化位置n-7可以借助13 C,C-6和1'-H之间的1 H-NMR远程偶联来确定.
    DOI:10.1002/jlac.198319830513

    海关参考信息

    专利信息


    专利号:US-11858953-B2
    优先权日:2018-04-04
    标 题:Compositions and methods for synthesis of phosphorylated molecules
    发明人:CHAPUT JOHN; LIAO JEN-YU; BALA SAIKAT
    权利人:UNIV CALIFORNIA
    摘要:The invention provides compositions and methods for synthesis of phosphorylated organic compounds, including nucleoside triphosphates.

    专利号:US-2020239500-A1
    优先权日:2018-04-04
    标 题 :Compositions and Methods for Synthesis of Phosphorylated Molecules

    专利号:EP-0604552-A4
    优先权日:1991-09-18
    标 题:PROCESS FOR THE SYNTHESIS OF VARIOUS COLLECTIONS OF OLIGOMERS.

    专利号:US-2021332070-A1
    优先权日:2018-04-04
    标题:Compositions and Methods for Synthesis of Phosphorylated Molecules

    专利号:US-11021497-B2
    优先权日:2018-04-04
    标题 :Compositions and methods for synthesis of phosphorylated molecules

    专利号:US-6165778-A
    优先权日:1993-11-02
    标 题 :Reaction vessel agitation apparatus
    发明人:KEDAR HAIM
    权利人:AFFYMAX TECH NV
    摘要:A device and method for efficiently synthesizing diverse molecular products on substrates. A parent vessel 200 contains a suspension of substrates. The suspension is pressurized with argon and transferred to a plurality of reaction vessels 201-209 in one or more reaction vessel banks where monomer addition reactions take place. Optionally, the substrates may be tagged with a tag monomer. A vortexing motor 300 vortexes the contents of reaction vessels 201-209 during monomer addition reactions to enhance synthesis. After the desired monomer and/or tag monomer addition reaction, the suspension is pressurized with argon and transferred back to parent vessel 200 for mixing. Thereafter, the suspension may be pressurized with argon and reallocated among reaction vessels 201-209 for further synthesis.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm00148a015
    摘要:Cottam HB, Kazimierczuk Z, Geary S, McKernan PA, Revankar GR, Robins RK. Synthesis and biological activity of certain 6-substituted and 2,6-disubstituted 2'-deoxytubercidins prepared via the stereospecific sodium salt glycosylation procedure. J Med Chem. 1985 Oct;28(10):1461–7. doi: 10.1021/jm00148a015.
    参考文献:10.1016/s0006-2952(02)01062-6
    摘要:Chen R, Jonker JW, Nelson JA. Renal organic cation and nucleoside transport. Biochem Pharmacol. 2002 Jul 15;64(2):185–90. doi: 10.1016/s0006-2952(02)01062-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知